Organizational Intelligence · MMT Premium

Food and Drug Administration
Leadership and Contracting Organization

Current as of August 25, 2026 • Acting Commissioner: Kyle Diamantas (since May 12, 2026) • Sources: fda.gov leadership profiles (July 31, 2026) · OAGS page
← FDA profile
ℹ
The most unsettled chart in this set. Commissioner Marty Makary resigned May 12, 2026; Kyle Diamantas is Acting, and the White House announced August 18 its intent to nominate Heidi Overton, MD (pending Senate confirmation, not yet on fda.gov). CDER and CBER are both on Acting directors, and CBER is on its 4th acting director and 6th leader since January 2025. The April 2025 RIF cut roughly 3,500 FTEs and eliminated nearly the whole Office of Digital Transformation executive team; the CIO seat is Acting. The stable island is the contracting shop: Leonard Grant has been the permanent HCA throughout.
Office of the Commissioner
Acting Commissioner
Kyle A. Diamantas, JD
Acting Commissioner of Food and Drugs
Since May 12, 2026 · nominee announced Aug 18: Heidi Overton, MD (pending confirmation, trade press)
Acting
Principal Deputy
VACANT
Principal Deputy Commissioner
Open Role
Chief of Staff
Lowell M. Zeta, JD
Acting Chief of Staff · Deputy Commissioner for Strategic Initiatives
Acting
Operations
Melanie Keller, MBA
Deputy Commissioner for Operations · COO
Policy & Legislation
Grace Graham, MPP
Deputy Commissioner for Policy, Legislation, and International Affairs
Science
Steven Kozlowski, MD
Chief Scientist
The Centers
Drugs
Michael Davis, MD, PhD
Acting Director, CDER
Acting
Biologics
Karim Mikhail, BPharm, MSc
Acting Director, CBER
4th acting director, 6th leader since Jan 2025
Acting
Devices · Digital Health
Michelle E. Tarver, MD, PhD
Director, CDRH
Digital Health Center of Excellence director: Rick Abramson, MD (Feb 2026, trade press; pending official confirmation)
Food (Replaced CFSAN)
Donald A. Prater, DVM
Acting Deputy Commissioner for Food, Human Foods Program
CFSAN no longer exists; the unified HFP replaced it
Acting
Tobacco
Bret Koplow, PhD, JD
Acting Director, CTP
Acting
Veterinary
Timothy C. Schell, PhD
Director, CVM
Oncology
Angelo de Claro, MD
Director, Oncology Center of Excellence
Inspections
Elizabeth Miller, PharmD
Associate Commissioner for Inspections and Investigations
Information Technology After the RIF
CIO
Sanjay Kumar Sahoo
Acting Chief Information Officer
The Office of Digital Transformation lost its CIO and nearly all executive leadership in the April 2025 RIF; ODT no longer appears on the May 2026 overview org chart and its formal status is unclear
Acting
Finance
Benjamin D. Moncarz
Chief Financial Officer
Medicine
VACANT
Chief Medical Officer
Open Role
The Contracting Chain (OAGS, under Operations)
HCA · Permanent
Leonard Grant
Head of Contracting Activity · Director, Office of Acquisitions and Grants Services
Verified on FDA's live OAGS page Aug 25, 2026; consistent with the April 2026 HHS HCA roster · Associate Director: Ron Loube
IT Acquisitions
Natalie Mitchell
Acting Director, Division of Information Technology Acquisitions (DITA)
All FDA IT buys flow through this division
Acting
Acquisition Operations
Vidya Vish
Director, Division of Acquisition Operations (professional services, training, BAA)
Policy & Systems
Bryan Jones
Director, Division of Policy, Systems and Program Support
Grants
Kimberly Pendleton
Director, Division of Grants, Agreements, and Acquisition Support
Caveat on the OAGS division roster: the OAGS page is live but its content date is January 7, 2025, which predates the April 2025 RIF. Grant and Loube are corroborated by the HHS roster; the division directors below them may have changed without the page updating. We flag rather than guess.
Sources. FDA leadership profiles (verified 2026-08-25, content current 2026-07-31, fda.gov). FDA overview org chart, text version (fda.gov, current 2026-05-20). Acting Commissioner page (fda.gov, current 2026-05-15). OAGS and additional resources (fda.gov). HHS restructuring fact sheet (hhs.gov). Makary resignation, Overton nomination, CBER succession, DHCoE appointment, and RIF detail: STAT, CNBC, AABB, FedScoop reporting, annotated in-line where pending official confirmation. Data current as of August 25, 2026.

What changed since this was published? Vacancies fill. Acting designations turn Permanent. We re-verify quarterly. If you spot a stale entry, email mary@missionmeetstech.com · we will update and re-cite.